This study is in progress, not accepting new patients
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Summary
- Eligibility
- for people ages 18-55 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT01194570
- Phase
- Phase 3 Multiple Sclerosis Research Study
- Study Type
- Interventional
- Participants
- About 732 people participating
- Last Updated